1.Characterization of inpatients in the department of cardiovascular medicine in a tertiary hospital fol-lowing chest pain center accreditation
Xuankun CAI ; Yongsheng HUANG ; Jingwei QIU ; Fanfang ZENG
Modern Hospital 2025;25(11):1781-1785
Objective This study aims to analyze the characteristics of inpatients in the cardiovascular department of a tertiary hospital following the chest-pain-center accreditation,and provide guidance for the prevention and treatment of cardiovas-cular diseases.Methods A retrospective descriptive epidemiological approach was adopted to analyze the data of 2115 inpatients at the department of cardiovascular medicine in a tertiary hospital from 2022 to 2024 following chest pain center accreditation.Re-sults The number of the inpatients in 2022,2023,and 2024 was 582 cases(27.52%),684 cases(32.34%),and 849 cases(40.14%),respectively,with the total rising year by year.The proportion of males was higher than that of females,with a male-to-female sex ratio of 1.45∶1.The group aged 40 to 79 years accounted for the highest percentage(80.90%).The top three diseases categorized by percentage were coronary heart disease(754 cases,35.64%),hypertension(479 cases,22.64%),and arrhythmia(167 cases,7.89%).Epidemiological characterization exhibited a statistically significant difference in the disease composition of hospitalized cardiovascular patients in years,genders,ages,and seasons(x2=155.40,36.591,900.597,856.659,P<0.05).Specific classification showed significant differences in hypertension and other conditions by age(P<0.05);coronary heart disease and valvular heart disease by gender(P<0.05);and significant differences across ages in coronary heart disease,hypertension,heart failure,pericardial disease,peripheral vascular disease,congenital heart disease,and others(all P<0.05).Seasonal differences in coronary heart disease,hypertension,arrhythmia,cardiomyopathy,valvular heart disease,heart failure,pericardial disease,and others were also statistically significant(P<0.05).Conclusion Against the backdrop of chest pain center accreditation in our hospital,inpatients in our department now demonstrate extinct demographic profiles and seasonal patterns among hospitalized cardiovascular patients.We should strengthen the prevention and treatment of coronary heart disease and hypertension,and establish a comprehensive prevention and control system based on these epidemio-logical characteristics.
2.Characterization of inpatients in the department of cardiovascular medicine in a tertiary hospital fol-lowing chest pain center accreditation
Xuankun CAI ; Yongsheng HUANG ; Jingwei QIU ; Fanfang ZENG
Modern Hospital 2025;25(11):1781-1785
Objective This study aims to analyze the characteristics of inpatients in the cardiovascular department of a tertiary hospital following the chest-pain-center accreditation,and provide guidance for the prevention and treatment of cardiovas-cular diseases.Methods A retrospective descriptive epidemiological approach was adopted to analyze the data of 2115 inpatients at the department of cardiovascular medicine in a tertiary hospital from 2022 to 2024 following chest pain center accreditation.Re-sults The number of the inpatients in 2022,2023,and 2024 was 582 cases(27.52%),684 cases(32.34%),and 849 cases(40.14%),respectively,with the total rising year by year.The proportion of males was higher than that of females,with a male-to-female sex ratio of 1.45∶1.The group aged 40 to 79 years accounted for the highest percentage(80.90%).The top three diseases categorized by percentage were coronary heart disease(754 cases,35.64%),hypertension(479 cases,22.64%),and arrhythmia(167 cases,7.89%).Epidemiological characterization exhibited a statistically significant difference in the disease composition of hospitalized cardiovascular patients in years,genders,ages,and seasons(x2=155.40,36.591,900.597,856.659,P<0.05).Specific classification showed significant differences in hypertension and other conditions by age(P<0.05);coronary heart disease and valvular heart disease by gender(P<0.05);and significant differences across ages in coronary heart disease,hypertension,heart failure,pericardial disease,peripheral vascular disease,congenital heart disease,and others(all P<0.05).Seasonal differences in coronary heart disease,hypertension,arrhythmia,cardiomyopathy,valvular heart disease,heart failure,pericardial disease,and others were also statistically significant(P<0.05).Conclusion Against the backdrop of chest pain center accreditation in our hospital,inpatients in our department now demonstrate extinct demographic profiles and seasonal patterns among hospitalized cardiovascular patients.We should strengthen the prevention and treatment of coronary heart disease and hypertension,and establish a comprehensive prevention and control system based on these epidemio-logical characteristics.
3.Trends and age-period-cohort analysis of leukemia incidence in Qidong from 1972 to 2021
Jian ZHU ; Yongsheng CHEN ; Jun WANG ; Yonghui ZHANG ; Lulu DING ; Yuanyou XU ; Yongfeng YAN ; Jianguo CHEN ; Hong CAI
Chinese Journal of Oncology 2024;46(10):961-967
Objective:To describe the epidemiological characteristics and trends of leukemia incidence in Qidong between 1972 and 2021, and provide guidelines for prevention and control measures and strategies.Methods:The cancer registry data was collected and analyzed on leukemia incidence during 1972—2021 in Qidong by sex, age and time. Crude incidence rate (CR), China age-standardized rate (ASRC), world age-standardized rate (ASRW), and average annual change percentage (AAPC) was calculated by Joinpoint software. Age-period-cohort (APC) model was used to analyze the influence of age, period and birth cohort on the changes in the incidence trend of leukemia patients.Results:From 1972 to 2021, there were 2 948 patients with leukemia in Qidong, accounting for 2.00% of all cancer new cases, CR of leukemia was 5.26/10 5, ASRC was 4.34/10 5, ASRW was 4.35/10 5. The truncated incidence of 35—64 years old was 5.29/10 5, the cumulative incidence rate between the ages of 0 and 74 years old was 0.40%, the cumulative risk was 0.40%. There were 1 608 male patients, the CR, ASRC, and the ASRW were 5.81/10 5, 4.88/10 5 and 4.85/10 5. The number of female patients were 1 340, and the CR, ASRC, and the ASRW were 4.71/10 5, 3.86/10 5 and 3.91/10 5, respectively. Temporal trends indicated significant upward trends in ASRC among both gender, males and females with AAPC values of 1.41% ( P<0.001), 1.15% ( P<0.001), and 1.73% ( P<0.001), respectively. The results of the APC model showed that the average net drift value of leukemia incidence in all age groups was 1.57% (95% CI, 1.24%-1.89%), and the highest value of local drift was 3.20% (95% CI, 1.63%-4.78%) in the 80~ years old group. The incidence of leukemia increased with age. With the passage of time, the risk of leukemia incidence increased gradually compared with the rate ratio of leukemia incidence (risk ratio [ RR], 1.00) in 1992—1996, the RR of leukemia incidence increased from 0.70 during 1972—1976 to 1.57 during 2017—2021. The later the cohort was born, the greater the risk of leukemia incidence compared with the relative risk of leukemia incidence ( RR, 1.00) in 1952—1956 cohort, the RR of leukemia incidence increased from 0.24 in the 1892—1896 cohort to 2.73 in the 2017—2021 cohort. Conclusions:The incidence of the leukemia has presented a rising trend in the past fifty years. Leukemia incidence increased with age, and the period and cohort effects on the risk of incidence increase. Further research is needed to investigate the risk factors related to leukemia.
4.Trends and age-period-cohort analysis of leukemia incidence in Qidong from 1972 to 2021
Jian ZHU ; Yongsheng CHEN ; Jun WANG ; Yonghui ZHANG ; Lulu DING ; Yuanyou XU ; Yongfeng YAN ; Jianguo CHEN ; Hong CAI
Chinese Journal of Oncology 2024;46(10):961-967
Objective:To describe the epidemiological characteristics and trends of leukemia incidence in Qidong between 1972 and 2021, and provide guidelines for prevention and control measures and strategies.Methods:The cancer registry data was collected and analyzed on leukemia incidence during 1972—2021 in Qidong by sex, age and time. Crude incidence rate (CR), China age-standardized rate (ASRC), world age-standardized rate (ASRW), and average annual change percentage (AAPC) was calculated by Joinpoint software. Age-period-cohort (APC) model was used to analyze the influence of age, period and birth cohort on the changes in the incidence trend of leukemia patients.Results:From 1972 to 2021, there were 2 948 patients with leukemia in Qidong, accounting for 2.00% of all cancer new cases, CR of leukemia was 5.26/10 5, ASRC was 4.34/10 5, ASRW was 4.35/10 5. The truncated incidence of 35—64 years old was 5.29/10 5, the cumulative incidence rate between the ages of 0 and 74 years old was 0.40%, the cumulative risk was 0.40%. There were 1 608 male patients, the CR, ASRC, and the ASRW were 5.81/10 5, 4.88/10 5 and 4.85/10 5. The number of female patients were 1 340, and the CR, ASRC, and the ASRW were 4.71/10 5, 3.86/10 5 and 3.91/10 5, respectively. Temporal trends indicated significant upward trends in ASRC among both gender, males and females with AAPC values of 1.41% ( P<0.001), 1.15% ( P<0.001), and 1.73% ( P<0.001), respectively. The results of the APC model showed that the average net drift value of leukemia incidence in all age groups was 1.57% (95% CI, 1.24%-1.89%), and the highest value of local drift was 3.20% (95% CI, 1.63%-4.78%) in the 80~ years old group. The incidence of leukemia increased with age. With the passage of time, the risk of leukemia incidence increased gradually compared with the rate ratio of leukemia incidence (risk ratio [ RR], 1.00) in 1992—1996, the RR of leukemia incidence increased from 0.70 during 1972—1976 to 1.57 during 2017—2021. The later the cohort was born, the greater the risk of leukemia incidence compared with the relative risk of leukemia incidence ( RR, 1.00) in 1952—1956 cohort, the RR of leukemia incidence increased from 0.24 in the 1892—1896 cohort to 2.73 in the 2017—2021 cohort. Conclusions:The incidence of the leukemia has presented a rising trend in the past fifty years. Leukemia incidence increased with age, and the period and cohort effects on the risk of incidence increase. Further research is needed to investigate the risk factors related to leukemia.
5.Protective effect of glycyrrhiza polysaccharide on H2O2-induced oxidative stress damage in broiler liver cells
Xueying WANG ; Huining HOU ; Yongsheng AN ; Jia LU ; Rishun LI ; Cai ZHANG
Chinese Journal of Veterinary Science 2024;44(8):1773-1781
The purpose of this study was to explore the protective effect of glycyrrhiza polysaccha-ride on oxidative stress-induced liver cell damage in broiler chickens,and to study its mechanism of action.Primary broiler liver cells cultured in vitro were divided into blank control group,H2 O2 in-duction group,glycyrrhiza polysaccharide group and H2O2+glycyrrhiza polysaccharide group;CCK-8 reagent was used to detect liver cell activity in broiler chickens,JC-1 and DAPI staining kits were used to detect cell apoptosis,relevant kits were used to detect GSH-Px,SOD,CAT,MDA content,and T-AOC levels.qRT-PCR was used to detect antioxidant genes Nrf2,Keap-1,GPx1,SOD,CAT and inflammatory genes TLR4,MyD88,NF-κB,TNF-α、IL-6,IL-1β、IL-4 and IL-10.The results showed that compared with the H2O2 induced group,glycyrrhiza polysaccharide pretreat-ment could significantly enhance liver cell activity and reduce cell apoptosis in broiler chickens;compared with the H2O2 induced group,glycyrrhiza polysaccharide pretreatment could significant-ly increase cell GSH-Px,SOD,CAT,MDA content and T-AOC levels,and inhibit MDA genera-tion;qRT-PCR detection showed that glycyrrhiza polysaccharide could significantly increase the relative expression levels of Nrf2,Keap-1,GPx1,SOD,CAT,IL-4 and IL-10,while significantly re-ducing MyD88,NF-κB,TNF-α,IL-6 and IL-1β.The results indicated that glycyrrhiza polysaccha-ride enhance the activity of antioxidant enzymes by activating the Nrf2 signaling pathway and in-hibit TLR4 signaling pathway transduction,significantly improving oxidative stress damage in broiler liver cells.
6.Research on ventilator management pathway based on three-dimensional quality evaluation model
Yongsheng MA ; Kewei XU ; Lin CAI ; Jian GUO ; Liangsheng YANG ; Hong ZHOU
China Medical Equipment 2024;21(12):148-153
Objective:To explore the application value of ventilator management path based on three-dimensional quality evaluation model in ventilator management. Methods:Based on the structure-process-outcome model (referred to as the three-dimensional quality evaluation model),the evaluation index system of ventilator service management was developed. The service quality algorithm was used to conduct comprehensive evaluation of service quality,and the structural optimization,process strengthening and outcome-oriented measures of ventilator equipment service management were developed. A total of 62 ventilators in clinical use in General Hospital of the Western Theater Command of the PLA from January to June 2023 were selected,and the 50 ventilators used from January to March adopted the conventional experience management model (referred to as experience management model),the 50 ventilators (including 38 in use in the experience management model) from April to June adopted the ventilator management path based on three-dimensional quality evaluation model (referred to as the model management model). The self-made satisfaction questionnaire was used to investigate the satisfaction of ventilator patients with equipment service quality,and the comprehensive evaluation difference score of equipment service quality and equipment operation quality of the two management modes were compared. Results:The comprehensive evaluation difference scores of equipment structure service quality,process service quality and outcome service quality of the model management mode were (0.08±0.06) points,(0.11±0.07) points and (0.05±0.04) points,respectively,which were lower than those of the experience management mode,the difference was statistically significant (Z=2.290,2.024,2.724,P<0.05). The average satisfaction of patients on ventilator therapy in the ICU wards of the department of respiratory and critical care medicine,department of intensive care unit,department of emergency and other departments was (95.66±1.74)%,(96.51±1.37)%,(95.93±1.67)% and (96.56±1.28)%,respectively,which were higher than those of the experience management mode,the difference was statistically significant (Z=3.624,3.854,3.368,2.799,P<0.05). The average start-up operation rate and quality inspection pass rate of ventilator equipment were (95.38±1.67)%and (95.44±1.71)%,respectively,which were higher than those of experience management mode;the average failure rate was (1.23±0.98)%,which was lower than that of experience management mode,the difference was statistically significant (Z=2.219,2.733,3.005,P<0.05). Conclusion:The application of ventilator management path based on three-dimensional quality evaluation model can improve the quality of ventilator clinical service,enhance the satisfaction of clinical service,and improve the operation quality of equipment.
7.Research on ventilator management pathway based on three-dimensional quality evaluation model
Yongsheng MA ; Kewei XU ; Lin CAI ; Jian GUO ; Liangsheng YANG ; Hong ZHOU
China Medical Equipment 2024;21(12):148-153
Objective:To explore the application value of ventilator management path based on three-dimensional quality evaluation model in ventilator management. Methods:Based on the structure-process-outcome model (referred to as the three-dimensional quality evaluation model),the evaluation index system of ventilator service management was developed. The service quality algorithm was used to conduct comprehensive evaluation of service quality,and the structural optimization,process strengthening and outcome-oriented measures of ventilator equipment service management were developed. A total of 62 ventilators in clinical use in General Hospital of the Western Theater Command of the PLA from January to June 2023 were selected,and the 50 ventilators used from January to March adopted the conventional experience management model (referred to as experience management model),the 50 ventilators (including 38 in use in the experience management model) from April to June adopted the ventilator management path based on three-dimensional quality evaluation model (referred to as the model management model). The self-made satisfaction questionnaire was used to investigate the satisfaction of ventilator patients with equipment service quality,and the comprehensive evaluation difference score of equipment service quality and equipment operation quality of the two management modes were compared. Results:The comprehensive evaluation difference scores of equipment structure service quality,process service quality and outcome service quality of the model management mode were (0.08±0.06) points,(0.11±0.07) points and (0.05±0.04) points,respectively,which were lower than those of the experience management mode,the difference was statistically significant (Z=2.290,2.024,2.724,P<0.05). The average satisfaction of patients on ventilator therapy in the ICU wards of the department of respiratory and critical care medicine,department of intensive care unit,department of emergency and other departments was (95.66±1.74)%,(96.51±1.37)%,(95.93±1.67)% and (96.56±1.28)%,respectively,which were higher than those of the experience management mode,the difference was statistically significant (Z=3.624,3.854,3.368,2.799,P<0.05). The average start-up operation rate and quality inspection pass rate of ventilator equipment were (95.38±1.67)%and (95.44±1.71)%,respectively,which were higher than those of experience management mode;the average failure rate was (1.23±0.98)%,which was lower than that of experience management mode,the difference was statistically significant (Z=2.219,2.733,3.005,P<0.05). Conclusion:The application of ventilator management path based on three-dimensional quality evaluation model can improve the quality of ventilator clinical service,enhance the satisfaction of clinical service,and improve the operation quality of equipment.
8.Spatial transcriptome analysis of long non-coding RNAs reveals tissue specificity and functional roles in cancer.
Kang XU ; Xiyun JIN ; Ya LUO ; Haozhe ZOU ; Dezhong LV ; Liping WANG ; Limei FU ; Yangyang CAI ; Tingting SHAO ; Yongsheng LI ; Juan XU
Journal of Zhejiang University. Science. B 2023;24(1):15-31
Long non-coding RNAs (lncRNAs) play a significant role in maintaining tissue morphology and functions, and their precise regulatory effectiveness is closely related to expression patterns. However, the spatial expression patterns of lncRNAs in humans are poorly characterized. Here, we constructed five comprehensive transcriptomic atlases of human lncRNAs covering thousands of major tissue samples in normal and disease states. The lncRNA transcriptomes exhibited high consistency within the same tissues across resources, and even higher complexity in specialized tissues. Tissue-elevated (TE) lncRNAs were identified in each resource and robust TE lncRNAs were refined by integrative analysis. We detected 1 to 4684 robust TE lncRNAs across tissues; the highest number was in testis tissue, followed by brain tissue. Functional analyses of TE lncRNAs indicated important roles in corresponding tissue-related pathways. Moreover, we found that the expression features of robust TE lncRNAs made them be effective biomarkers to distinguish tissues; TE lncRNAs also tended to be associated with cancer, and exhibited differential expression or were correlated with patient survival. In summary, spatial classification of lncRNAs is the starting point for elucidating the function of lncRNAs in both maintenance of tissue morphology and progress of tissue-constricted diseases.
Humans
;
Gene Expression Profiling
;
Neoplasms/genetics*
;
Organ Specificity
;
RNA, Long Noncoding/genetics*
;
Transcriptome
9.Analysis of the relationship between venous thromboembolism after surgical treatment for bronchiectasis and preoperative hemoglobin amount
Yongsheng CAI ; Qingshan CHEN ; Honghong DONG ; Shuo CHEN ; Xin LI ; Xin YE ; Yili FU ; Qirui CHEN ; Bin YOU ; Jinbai MIAO ; Hui LI ; Bin HU
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2023;30(11):1561-1566
Objective To study the correlation of preoperative hemoglobin amount with venous thromboembolism (VTE) after surgical treatment of bronchiectasis and the clinical significance. Methods A retrospective study was performed on patients with bronchiectasis who underwent surgical treatment in our center from June 2017 to November 2021. The differences in blood parameters between the VTE patients and non-VTE patients were compared. The relationship between preoperative hemoglobin and VTE was confirmed by quartile grouping and receiver operating characteristic (ROC) curve. Results A total of 122 patients were enrolled, including 50 males and 72 females, with a mean age of 52.52±12.29 years. The overall incidence of VTE after bronchiectasis was 9.02% (11/122). Preoperative hemoglobin amount (OR=0.923, 95%CI 0.870-0.980, P=0.008) and D-dimer amount (OR=1.734, 95%CI 1.087-2.766, P=0.021) were independent influencing factors for VTE after bronchiectasis. The incidence of VTE after bronchiectasis decreased gradually with the increase of preoperative hemoglobin amount. The area under the ROC curve (AUC) of postoperative D-dimer alone was 0.757, whereas the AUC of postoperative D-dimer combined with preoperative hemoglobin amount was 0.878. Conclusion Low preoperative hemoglobin is an independent risk factor for postoperative VTE. Postoperative D-dimer combined with preoperative hemoglobin amount has a better predictive performance compared with postoperative D-dimer alone for postoperative VTE.
10.Study of ErChen decoction on the treatment of obesity polycystic ovary syndrome and obesity infertility
Mengcheng CAI ; Yongsheng JIN ; Chaoqin YU ; Wen CHENG ; Jin YU ; Ling ZHOU
Journal of Pharmaceutical Practice 2022;40(1):20-27
Objective To explore the potential mechanism of Erchen decoction in the treatment of obese polycystic ovary syndrome and obese infertility, in order to provide theoretical basis for “treating different diseases with same method”. Methods The active ingredients and targets of Erchen decoction were obtained from TCMSP database, and the targets of obese polycystic ovary syndromes and obese infertility were obtained from GeneCard database. Active ingredient-target network was constructed by Cytoscape 3.7.1, and protein-protein interaction network and core target were obtained from STRING. GO and KEGG enrichment analysis were performed by Cytoscape 3.7.1 and online software. Results 125 ingredients and 218 targets of Erchen decoction were obtained. There were 2 783 target genes for obese infertility and 2 962 target genes for obese polycystic ovary syndrome. Erchen decoction has a total of 117 target genes in the treatment of obese infertility and obese polycystic ovary syndromes, which proves the principle of “treating different diseases with same method”. Potential active ingredients include quercetin, kaempferol, naringin, baicalin and formononetin. PPI showed that STAT3, JUN, AKT1, MAPK3, MAPK1, MAPK14, IL-6 and FOS were the core targets of “treating different diseases with same method”. Molecular docking results showed that quercetin, kaempferol, etc. had good binding ability with JUN. GO and KEGG enrichment analysis showed that AGE-RAGE signaling pathway, IL-17 signaling pathway and endocrine resistance might be the key pathways for the “treating different diseases with same method” of Erchen decoction. Conclusion Erchen decoction treating "different diseases with same method" involves same targets and same pathways, which can provide reference for future experimental research.

Result Analysis
Print
Save
E-mail